These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 12834109)
1. Accumulation of phosphorylated alpha-synuclein in aging human brain. Saito Y; Kawashima A; Ruberu NN; Fujiwara H; Koyama S; Sawabe M; Arai T; Nagura H; Yamanouchi H; Hasegawa M; Iwatsubo T; Murayama S J Neuropathol Exp Neurol; 2003 Jun; 62(6):644-54. PubMed ID: 12834109 [TBL] [Abstract][Full Text] [Related]
2. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347 [TBL] [Abstract][Full Text] [Related]
3. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies. Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110 [TBL] [Abstract][Full Text] [Related]
5. Accumulation of human alpha-synuclein in different cytoskeletons in Lewy bodies in brains of dementia with Lewy bodies. Iseki E; Marui W; Sawada H; Uéda K; Kosaka K Neurosci Lett; 2000 Aug; 290(1):41-4. PubMed ID: 10925170 [TBL] [Abstract][Full Text] [Related]
6. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831 [TBL] [Abstract][Full Text] [Related]
7. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226 [TBL] [Abstract][Full Text] [Related]
8. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403 [TBL] [Abstract][Full Text] [Related]
9. Mapping of rat brain using the Synuclein-1 monoclonal antibody reveals somatodendritic expression of alpha-synuclein in populations of neurons homologous to those vulnerable to Lewy body formation in human synucleopathies. Andringa G; Du F; Chase TN; Bennett MC J Neuropathol Exp Neurol; 2003 Oct; 62(10):1060-75. PubMed ID: 14575241 [TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Mattila PM; Rinne JO; Helenius H; Dickson DW; Röyttä M Acta Neuropathol; 2000 Sep; 100(3):285-90. PubMed ID: 10965798 [TBL] [Abstract][Full Text] [Related]
11. Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. Katsuse O; Iseki E; Marui W; Kosaka K J Neurol Sci; 2003 Jul; 211(1-2):29-35. PubMed ID: 12767494 [TBL] [Abstract][Full Text] [Related]
12. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. Marui W; Iseki E; Nakai T; Miura S; Kato M; Uéda K; Kosaka K J Neurol Sci; 2002 Mar; 195(2):153-9. PubMed ID: 11897247 [TBL] [Abstract][Full Text] [Related]
13. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy. Nishie M; Mori F; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K Acta Neuropathol; 2004 Apr; 107(4):292-8. PubMed ID: 14722716 [TBL] [Abstract][Full Text] [Related]
14. Lewy body-related alpha-synucleinopathy in the aged human brain. Jellinger KA J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835 [TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification. Hishikawa N; Hashizume Y; Ujihira N; Okada Y; Yoshida M; Sobue G Neuropathol Appl Neurobiol; 2003 Jun; 29(3):280-7. PubMed ID: 12787325 [TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study. Jellinger KA Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452 [TBL] [Abstract][Full Text] [Related]
18. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein]. Iwatsubo T Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099 [TBL] [Abstract][Full Text] [Related]
19. Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies. Lee SS; Kim YM; Junn E; Lee G; Park KH; Tanaka M; Ronchetti RD; Quezado MM; Mouradian MM Neurobiol Aging; 2003 Sep; 24(5):687-96. PubMed ID: 12885576 [TBL] [Abstract][Full Text] [Related]
20. Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry. Iseki E; Marui W; Akiyama H; Uéda K; Kosaka K Neurosci Lett; 2000 May; 286(1):69-73. PubMed ID: 10822155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]